The 26th Annual International Symposium on Congenital Heart Disease in the Adult

Skamania Lodge

International faculty and attendees have gathered annually to educate, learn and receive updates about the latest innovations in diagnosis and management for adult congenital heart disease.

The 2016 symposium will be held June 1-4, 2016 at the Skamania Lodge outside of Portland, Oregon.


OHSU School of Medicine, Division of CPD, designates this live activity for a maximum of 23.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Lodging options

Alternative lodging options map

2016 Program overview

Wednesday, June 1

The ACHD field from all angles (Sahn/Burchill Moderating)

8:00-8:05 Welcome and Introduction (Sahn)

8:05-8:20 The rising tide of ACHD patient volume and how programs need to adjust (Oechslin)

8:25-8:40 ACHA vision for the ACHD community (Tringali)

8:45-9:00 Patient perspectives on championing the CHD cause (Aicher)

9:05-9:20 AHA/CHF joint funding opportunities (Ivy/Julie)

9:25-9:40 Fit bit frenzy; tips for providers on patient self quantification (Kaufman)




Breakout for Early Career Providers (Krieger Moderating)

10:30-10:42 ACHD fellowship pathways and options for today (Stout)

10:45-10:57 Online training resources at your disposal (Webb)

11:00-11:12 ACHD Board preparation advice (Saidi)

11:15-11:27 Strategies for program development (Meadows)

11:30-11:42 Discussion


Breakout for CCAs (Woods Moderating)

10:30-10:42 The psychology and mechanics of "transition" (Williams)

10:45-10:57 Social media as a resource for patient communication (Fernandes)

11:00-11:12 Making an effort to find the "lost" (Miner)

11:15-11:27 Sports in ACHD and how to advise patients (Shafer)

11:30-11:42 Discussion


Breakout for Program Directors (Yetman Moderating) 

10:30-10:42 ACGME fellowship requirements and their rationales (Landzberg)

10:45-10:57 Straight talk about ACHA program accreditation (Daniels)

11:00-11:12 Electronic multicenter registries; feasibility and reality (Broberg)

11:15-11:27 Quality Metrics: Performance enhancement or major migraine? (Marelli)

11:45-12:40 LUNCH Cardiac Care Associates Lunch

11:30-11:42 Discussion


Innovation in multicenter ACHD data (O'Donnell/Marelli Moderating)

12:45-12:50 A few words about this years Symposium (Broberg)

12:55-13:10 The ROPAC study and how we did it (Roos-Hesselink)

13:15-13:30 The NOTE registry and how we are doing it (Mulder)

13:35-13:50 Obstacles and successes in utilizing administrative US healthcare data (Karamlou)

13:55-14:10 The multicenter TACTIC study, lessons learned (Khairy (prerecorded video))

14:15-14:20 Discussion




Perioperative ACHD (Fuller/Karamlou Moderating)

14:55-15:10 Prehabillitation--how to make surgery safer (Burchill)

15:15-15:30 Cardiac congenital surgery and short term mortality in the UK (Kempny)

15:35-15:50 Anesthesia perspective on improving surgical outcomes (Maxwell)

15:55-16:10 Hybrid hype or necessity? what does a combined surgical/interventional lab offer in ACHD? (Jones)

16:15-16:30 What the airline industry can teach us about surgical teams (Hickey)

16:35-16:40 Discussion




Contemporary Research (Khan/Deen Moderating)

17:15-17:27 The 10 most important ACHD research publications in the last 2 years (Webb)

17:30-17:42 Oral Abstract Presenter 1

17:45-17:57 Oral Abstract Presenter 2

18:00-18:12 Oral Abstract Presenter 3

18:15-18:27 Oral Abstract Presenter 4


18:30-19:25 DINNER BUFFET

19:30-19:45 David Sahn Recognition

Thursday, June 2

6:30-7:55 morning run, swim, or morning yoga


The systemic RV and what it needs (Cedars/Morrison Moderating)

8:00-8:15 Strain imaging for the systemic RV: Ready for prime time? (Davidson)

8:20-8:35 CRT for the systemic RV? When and how? (Seslar)

8:40-8:55 ARBS and the systemic RV: What we do with our patients and why (Mulder)

9:00-9:15 Mechanical support for the systemic RV (Hermsen)

9:20-9:35 Emerging features of the Hypoplastic Left Heart cohort (Wilson)

9:40-9:40 Discussion




Fontan Considerations I (McConnell/John Moderating)

10:15-10:30 Who does well and why: Understanding prognosis in Fontan (Kempny)

10:35-10:50 How do we define "Fontan Failure"? (Burchill)

10:55-11:10 Latest rationale and data on pulmonary vascular therapy in Fontan (Aboulhosn)

11:15-11:30 "Double double coil and trouble": When and why should collaterals be closed? (Wilson)

11:35-11:50 Report from the "Fontan and Liver Disease" ACC Consortium (Daniels)

11:55-12:05 Discussion


12:10-12:20 Box Lunch Break


Case-based Fontan Challenges (Webb Moderating)

12:25-12:30 Discussants: Veldtman, Warnes, Landzberg, Colman, Fuller, Chen




18:30-18:55 AARCC Research Meeting (All Welcome)


19:00-19:10 Buffet Dinner and Evening Session (Kovacs Moderating)

19:15-19:27 The ABIM exam: How did we do? (Aboulhosn)

19:30-19:42 New Guidelines and the ACHD classification scheme (Colman)

19:45-20:00 Special Lecture: The Evolving Surgeon-Cardiologist Relationship (Williams)


20:05-20:30 Table Trivia


20:35-22:00 Live music from Portland (dancing shoes optional)

Friday, June 3

6:30-7:55 morning run, swim, or morning yoga


Shunts and the Pulmonary Vasculature (Grewal/Zaidi Moderating)

8:00-8:15 Prevalence of PAH in CHD (Celermajer)

8:20-8:35 Best advice for hemodynamic assessment and interpretation in patients with an ASD (Nishimura)

8:40-8:55 Pulmonary vasoreactive medications and decisions about shunt closure (Bradley)

9:00-9:15 QUERI ES and lessons learned thus far (Daniels)

9:20-9:35 Disease targeting therapies in Eisenmenger Syndrome: do they make a difference? If so, what do they do? (Opotowsky)

9:40-9:55 Discussion




10:30-12:05 BREAKOUT

Aortopathy from Bench to Bedside (Yetman/Kay Moderating)

10:30-10:45 Deciding when to operate in bicuspid valve aortopathy (Nishimura)

10:50-11:05 When is genotyping for aortopathies a good idea? (Byers)

11:10-11:25 Fibrillin in the ED as a real-time risk assessment marker (Sakai)

11:30-11:45 Marfan pharmacotherapy; what do we do now? (M. Singh)

11:50-12:05 Unique considerations of Turner syndrome aortopathy and dissection risk (Silberbach)


Pregnancy Management (Swan/Canobbio Moderating)

10:30-10:45 Latest data on pregnancy and mechanical heart valves (Roos-Hesselink)

10:50-11:05 Should she push? Second stage labor decisions (Khan)

11:10-11:25 Cardiac procedures during pregnancy - who, what, when and how? (Warnes)

11:30-11:45 Managing the dilated aorta throughout pregnancy and labor (Silversides)

11:50-12:05 Discussion


12:10-12:55 LUNCH


Fontan Considerations II (Cotts/Veldtman Moderating) 

13:00-13:15 The Australia/New Zealand Fontan Registry (Celermajer)

13:20-13:35 Today's best management strategies for PLE (John)

13:40-13:55 Lymphatics as a potential therapeutic target (Dori)

14:00-14:15 Emerging mechanical support for the failing Fontan (Jones)

14:20-14:35 Transplant considerations--when, where, and what? (Fuller)

14:40-14:55 Discussion




15:30-16:25 Case-based Workshops


Electrophysiology from the Inside Out (Balaji Moderating) 

15:30-15:42 What's new in catheter ablation for ACHD (Moore)

15:45-15:57 S-ICDs and their implications in ACHD (Seslar)

16:00-16:12 Complex lead extraction successes and failures (Henrikson)

16:15-16:27 VT ablation techniques--an unexplored option? (Robinson)


End of Life Considerations (Saidi Moderating) 

15:30-15:42 Palliative care considerations (Steiner)

15:45-15:57 How and when to discuss device deactivation (Kirkpatrick)

16:00-16:12 Understanding "enough is enough" at age 25 (Kovacs)

16:15-16:27 Discussion


Restoration Hardware: Interventional Pearls and Pitfalls (H. Singh Moderating) 

15:30-15:42 Mustard/Senning meets cath lab (Kay)

15:45-15:57 Fontan Cath Intervention (Dori)

16:00-16:12 Aortic intervention in the cath lab (Steinberg)

16:15-16:27 Aortic intervention in the operating room (Chen)


Clinical Decisions through Imaging (Cedars Moderating) 

15:30-15:42 Exactly how should we measure the aorta? Multimodality considerations (Broberg)

15:45-15:57 Ebstein imaging with echo and CMR: How to direct surgical decision making (Connolly)

16:00-16:12 A closer look at the myocardium through advanced imaging in congenital heart disease. (Krieger)

16:15-16:27 What should determine when a coarctation patient should be cathed? (Meadows)



18:00 Ride/Walk to the boat dock

Sternwheeler Dinner Cruise 

18:30-20:55 Boat leaves dock


21:30-22:25 Garfunkel, Dylan, McCarthy, and Sahn: Campfire Songfest and S'mores

Saturday, June 4

7:30-7:55 checkout/breakfast


The Pulmonary Valve and its Implications (Lui/Singh Moderating)

8:00-8:15 Consideration of tricuspid regurgitation in the setting of pulmonary regurgitation (Bouma)

8:20-8:35 Should expectation of a future percutaneous pulmonary valve change timing of PVR surgery? (Landzberg)

8:40-8:55 Unchained Melody--monitoring for endocarditis, stent fractures, etc post deployment (Kay)

9:00-9:15 The fate of the bioprosthetic pulmonary valve (Connolly)

9:20-9:25 Discussion




Guns Blazing: Wild West Debates of ACHD Controversies (Colman Moderating)

10:00-10:12 Primary prevention ICD in a systemic RV with EF<30%? YES: The electric safety net! (Stout)

10:15-10:27 Primary prevention ICD in a systemic RV with EF<30%? NO: Keep calm and carry on. (Opotowsky)

10:30-10:42 A congenital heart surgeon is imperative to ACHD care (Hickey)

10:45-10:57 A conenital heart surgeon is not as essential as we think (Landzberg)

11:00-11:05 Discussion


Meeting Wrap Up (Burchill Moderating) 

11:10-11:30 Thriving and surviving as an ACHD practitioner (Kovacs)

11:30-11:50 Keynote Address: Lessons from the past, directions for the future (Warnes)

11:50-11:55 Abstract Awards presentation and invite to next year